MYC as a target for cancer treatment
Michael J. Duffy(University College Dublin), John Crown(St. Vincent's University Hospital)
Cited by 528
Related Papers
The urokinase-type plasminogen activator system in cancer metastasis: A review
|International Journal of Cancer|1997|1.6k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
|Clinical Chemistry|2001|799
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
|Breast Cancer Research|2000|632
Mutant p53: a novel target for the treatment of patients with triple‐negative breast cancer?
|International Journal of Cancer|2016|110